In early March, Century Therapeutics made waves by raising $160 million in Series C financing. This was on top of the existing $250 million that the company raised during a Series A round in 2019, bringing its total financing to an astounding $410 million. The Series C financing round was led by Casdin Capital, a New York-based investment firm that targets life science and healthcare companies. [Read more…]
denovoMATRIX Launches New Enabling Technology for High-Quality Induced Pluripotent Stem Cell Culture
DRESDEN, Germany, Mar. 22, 2021 (BioInformant) — denovoMATRIX GmbH, a developer of technologies which enable high quality stem cell expansion, announced the launch of a new range of products for the expansion, banking and maintenance of induced pluripotent stem cells (iPSC). The product line, termed myMATRIX iPSC, are chemically defined, ready-to-use consumables, designed to simplify and accelerate iPSC culture. [Read more…]
DVC Stem: Stem Cell Therapy Clinic in the Cayman Islands
*Sponsored Content: This article is sponsored by DVC Stem.
DVC Stem is an innovative stem cell therapy clinic in the Cayman Islands. The clinic’s Medical Director, Dr. Cona, is a pioneer in regenerative cell therapy, providing the first stem cell treatments in the Cayman Islands more than a decade ago. He continues to research alternative therapies for various medical conditions, and with IRB certified clinical trials, has treated local and international patients for Multiple Sclerosis (MS), Chronic Low Grade Inflammation (which is part of the overall Aging Process), and many other degenerative conditions.
Dr. Cona is certified by the American Academy of Aesthetic Practitioners, and is also a member of the World Academy of Anti-Aging Medicine (WAAAM). He is a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians. [Read more…]
Notch Therapeutics Closes $85M Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies
— Financing supports advancement of initial T cell-based pipeline for cancer and
expanded development of Engineered Thymic Niche (ETN) platform for multiple immune cell types—
VANCOUVER, British Columbia, February 10, 2021— Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced today the closing of an oversubscribed U.S. $85 million Series A financing. [Read more…]
LifePlus Stem Cells Delivers its First Allogeneic Mesenchymal Stem Cells for the Treatment of Arthritis
LifePlus Stem Cells, a provider of innovative stem cell advancements, specialising in regenerative rehabilitation announces their first injection of its umbilical cord-derived allogeneic mesenchymal stem cells. Using a unique and highly regulated manufacturing process, LifePlus Stem Cells is able to provide patients and clinicians with the world’s purest allogeneic mesenchymal stem cells – achieving purity levels of well over 80%.
- « Previous Page
- 1
- …
- 92
- 93
- 94
- 95
- 96
- …
- 201
- Next Page »




